<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[astrazeneca plc. and daily mail Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/astrazeneca+plc.+and+daily+mail.html?i=11]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to astrazeneca plc. and daily mail]]></description>
	<s:counts start="0" returned="10" found="10" />
	<language>en-us</language>
	<item>
		<title><![CDATA[AstraZeneca's Crestor hit but fat-buster drugs get thumbs-up.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200411/ai_n22277782]]></link>
		<description><![CDATA[Daily Mail, London Knight Ridder/Tribune Business News    Daily Mail, London Knight Ridder/Tribune Business News  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 23 Nov 2004 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[British drugmaker AstraZeneca fails to clear U.S. hurdle on new drug.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200410/ai_n22249711]]></link>
		<description><![CDATA[By Ian Lyall, Daily Mail, London Knight Ridder/Tribune Business  News    By Ian Lyall, Daily Mail, London Knight Ridder/Tribune Business  News  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 07 Oct 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[AstraZeneca comes out fighting to quash fears over anti-cholesterol drug.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200407/ai_n22207881]]></link>
		<description><![CDATA[Daily Mail, London Knight Ridder/Tribune Business News    Daily Mail, London Knight Ridder/Tribune Business News  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 23 Jul 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[AstraZeneca Seeks Approval from European Officials to Launch Cancer Drug.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200302/ai_n21758882]]></link>
		<description><![CDATA[Daily Mail, London Knight Ridder/Tribune Business News    Daily Mail, London Knight Ridder/Tribune Business News  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 12 Feb 2003 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[CEO of AstraZeneca Responds to Pressure on Pharmaceutical Industry.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200301/ai_n21750523]]></link>
		<description><![CDATA[By Cliff Feltham, Daily Mail, London Knight Ridder/Tribune Business  News    By Cliff Feltham, Daily Mail, London Knight Ridder/Tribune Business  News  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 30 Jan 2003 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[Deaths from Side Effects of Cancer Drug Shakes British Drugmaker AstraZeneca.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200212/ai_n21729644]]></link>
		<description><![CDATA[Daily Mail, London Knight Ridder/Tribune Business News    Daily Mail, London Knight Ridder/Tribune Business News  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 27 Dec 2002 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[AstraZeneca to Sell New Drug in Holland.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200211/ai_n21714990]]></link>
		<description><![CDATA[By Cliff Feltham, Daily Mail, London Knight Ridder/Tribune Business  News    By Cliff Feltham, Daily Mail, London Knight Ridder/Tribune Business  News  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 08 Nov 2002 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[AstraZeneca Hit by Demands to Fire Directors, Competition for Star Drug.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200204/ai_n21614600]]></link>
		<description><![CDATA[Daily Mail, London Knight Ridder/Tribune Business News    Daily Mail, London Knight Ridder/Tribune Business News  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 24 Apr 2002 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[AstraZeneca Calls Off Launch of Bronchitis Treatment.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200106/ai_n21518634]]></link>
		<description><![CDATA[By Cliff Feltham, Daily Mail, London Knight Ridder/Tribune Business  News    By Cliff Feltham, Daily Mail, London Knight Ridder/Tribune Business  News  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 28 Jun 2001 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[AstraZeneca.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5555/is_200105/ai_n21936760]]></link>
		<description><![CDATA[Byline: Daily Mail    Byline: Daily Mail  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 21 May 2001 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/daily+mail.html"><![CDATA[Daily Mail]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
</channel>
</rss>
